# British drugs giant Astrazeneca has promised to plough £300m into its UK operations, just months after cancelling a nine-figure investment in a new lab.

*biotech · news · 2026-04-29 · City A.M.*

## Key points

- Astrazeneca has reversed its prior decision and will invest £300m in UK operations.
- The revived Cambridge megalab project and £100m for Macclesfield comprise the largest recent UK pharma investment.
- Astrazeneca's investment hinges on a new UK-US trade deal that raised NHS drug prices and secured tariff-free US access.
- The Rosalind Frank building in Cambridge and the Macclesfield site will gain digital drug development capabilities.
- This investment is expected to secure up to 1,000 jobs in Cambridge and Macclesfield.

**Companies:** Astrazeneca, GSK, Merck
**Countries:** United Kingdom, United States

[Read the full story on City A.M.](https://www.cityam.com/astrazeneca-to-plough-300m-into-uk-operations/)

---

Canonical: https://newsio.io/n/cb0e02ba-939e-45a6-8c0d-ebeef82404c0/british-drugs-giant-astrazeneca-has-promised-to-plough-300m-into-its-uk-operatio
Summarized by Newsio from City A.M.. https://newsio.io/how-it-works